October 27 2015 Issue
1) Infection, vaccination and childhood arterial ischemic stroke and 2) Topic of the month: Neurology Today: Recent Publications. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark McAllister interviews Dr. Heather Fullerton about her paper on infection, vaccination and childhood arterial ischemic stroke. Dr. Adam Numis is reading our e-Pearl of the week about Lafora body disease. In the next part of the podcast Dr. Ted Burns interviews Dr. Jim Bernat about his Neurology To...
Source: Neurology Podcast - October 26, 2015 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts
August 2015: Predictors of Recurrent Stroke
ARTICLE DISCUSSED: Predictors of Recurrent Stroke in Patients with Ischemic Stroke: Comparison Study between Transesophageal Echocardiography and Cardiac CT. Radiology 2015;276(2):381-389. (Source: Radiology Podcasts)
Source: Radiology Podcasts - July 23, 2015 Category: Radiology Authors: The Radiological Society of North America Tags: Podcasts Source Type: podcasts
August 2015: Predictors of Recurrent
Stroke
ARTICLE DISCUSSED: Predictors of Recurrent Stroke in Patients with Ischemic Stroke:
Comparison Study between Transesophageal Echocardiography and Cardiac CT. Radiology 2015;276(2):381-389. (Source: Radiology Podcasts)
Source: Radiology Podcasts - July 23, 2015 Category: Radiology Authors: The Radiological Society of North America Tags: Podcasts Source Type: podcasts
May 2015: Multiphase CT Angiography
ARTICLE DISCUSSED: Multiphase CT Angiography: A New Tool for the Imaging Triage of Patients with Acute Ischemic Stroke. Radiology 2015;275(2):510-520. (Source: Radiology Podcasts)
Source: Radiology Podcasts - April 23, 2015 Category: Radiology Authors: The Radiological Society of North America Tags: Podcasts Source Type: podcasts
May 2015: Multiphase CT
Angiography
ARTICLE DISCUSSED: Multiphase CT Angiography: A New Tool for the Imaging
Triage of Patients with Acute Ischemic Stroke. Radiology 2015;275(2):510-520. (Source: Radiology Podcasts)
Source: Radiology Podcasts - April 23, 2015 Category: Radiology Authors: The Radiological Society of North America Tags: Podcasts Source Type: podcasts
Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.
In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.
In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.
Read their full analysis:
http://www.bmj.com/content/350/bmj.h1075 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: Journals (General) Authors: BMJ talk medicine Source Type: podcasts
Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.
In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.
Read their full analysis:http://www.bmj.com/content/350/bmj.h1075 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.
In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and... (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Thrombolysis in acute ischaemic stroke - time for a rethink?
In the US the licence, or marketing authorisation, for alteplase is limited to 0-3 hours after onset of stroke, but some other countries - including the UK and Australia - have extended the licence to 4.5 hours.
In an analysis article on thebmj.com Brian Alper, vice president of evidence based medicine research and development at Dynamed, and colleagues, interpret the evidence to suggest increased mortality with uncertain benefit for its use beyond three hours.
Read their full analysis:
http://www.bmj.com/content/350/bmj.h1075 (Source: The BMJ Podcast)
Source: The BMJ Podcast - March 18, 2015 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Cerebral Microbleeds, Stroke, and Atrial Fibrillation
The presence and burden of cerebral microbleeds has a significant effect on mortality in patients with nonvalvular AF and ischemic stroke. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - March 12, 2015 Category: Neurology Authors: Medscape Source Type: podcasts
